A biotech company backed by Chinese conglomerate Fosun Group and private equity giant Warburg Pincus has begun one of the first mid-stage human trials of a drug discovered and designed by artificial intelligence.
由中國復(fù)星集團(tuán)(Fosun Group)和私募股權(quán)巨頭華平投資支持的一家生物技術(shù)公司，已經(jīng)開始對一款由人工智能發(fā)現(xiàn)和設(shè)計的藥物進(jìn)行首批中期人體試驗(yàn)。
您已閱讀7%（463字），剩余93%（5961字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。